Safelayer Receives the Frost & Sullivan Marketing Strategy Leadership Award in Global PKI Systems
|
| Posted
:
Mon, 06 Jul 2009 10:02:56 GMT |
| Author
:
Safelayer Secure Communications |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
BARCELONA, July 6 Safelayer-Secure-Comm
BARCELONA, July 6 /PRNewswire/ --
- According to the Business Research & Consulting Firm Frost & Sullivan,
Safelayer is Ideally Positioned for Growth in Europe and Latin America
Safelayer Secure Communications (http://www.safelayer.com) has received
the Market Strategy Leadership Award from Frost & Sullivan. The business
research & consulting firm believes Safelayer's marketing strategy has
demonstrated its worth and effectiveness against the competition. With a
strong commitment to R&D and to continually improving its product portfolio,
Safelayer has taken steps to increase its market share in Brazil, Chile,
Colombia, Uruguay, Italy, France, Portugal, Poland and Morocco.
Safelayer's strategic technology and its success in national and
international projects have allowed the company to become an industry
specialist in the European and Southern Cone markets. Its digital
identification, electronic signature and data protection solutions are
present in large corporations and in the administration, defense, banking and
insurance and health sectors. According to Frost & Sullivan, "In addition to
selling to government agencies and financial institutions, Safelayer focuses
on large enterprise accounts and the expansion of its technology into
Certification Authorities (CSPs) that are located in various global markets."
From its dominant position in the Spanish market, Safelayer is working to
reinforce and expand its presence in EMEA and LATAM. The company is currently
developing its products and targeting, in partnership with VARs, new markets
in fourteen countries. As the leader in its domestic market, Safelayer
solutions are being used in the three major digital certification and
identification projects in Spain that target over 40 million people: the
citizen e-ID card, electronic passport and CERES-FNMT (Royal Spanish Mint)
Certification Authority, making it a pioneer in the development of
large-volume critical identity management projects.
Founded in 1999, Safelayer actively takes part in R&D projects,
participates in global technical forums on interoperability and has received
several awards, such as the TeleTrust innovation award given to its TrustedX
product for its problem-solving potential, interoperability, international
relevance and European scope. According to Francisco Jordan, Safelayer's CEO
and co-founder, "our strategy is based on providing intelligent systems and
maximum integration for deploying and managing information security and
trust. We achieve this with greater guarantees of compliance with the
standards and reliability that meets all applicable technical and legal
requirements for quality and security."
About Safelayer
Founded in 1999, Safelayer operates from its head offices in Barcelona
and Madrid. It is a leader in developing security and trust products for
digital identification, electronic signature and data encryption. Safelayer's
KeyOne product family implements advanced public key infrastructures (PKI)
for managing digital certificates, certificate validation and electronic
time-stamping. Safelayer's TrustedX trusted services platform provides
applications with information security mechanisms-for electronic documents
and web messaging-using a SOA (services-oriented architecture) and XML
approach.
Source: Safelayer Secure Communications, http://www.safelayer.com
SOURCE Safelayer Secure Communications
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
Capital Injection Changes for the NEC Electronics and Renesas Business Integration Tokyo, Nov 9, 2009 - (JCN Newswire) - NEC Electronics Corporation (NEC Electronics; TSE: 6723), Renesas Technology Corp.(Renesas), NEC Corporation (NEC; TSE: 6701), Hitachi, Ltd. (Hitachi; TSE: 6501 / NYSE: HIT), and Mitsubishi Electric Corporation (Mitsubishi Electric; ...
Fujitsu Interstage BPM Version 11 Lets Businesses Proactively "Sense and Respond" to Change Tokyo, Nov 9, 2009 - (JCN Newswire) - Fujitsu today announced the worldwide release of Interstage? Business Process Manager (BPM) Version 11, offering enhanced "Sense and Respond" capabilities that let users proactively address changing business requirements. T...
Notice Concerning Capital Injection Changes for the NEC Electronics and Renesas Business Integration KAWASAKI, Japan & TOKYO -
NEC Electronics Corporation (NEC Electronics; TSE: 6723), Renesas
Technology Corp. (Renesas), NEC Corporation (NEC; TSE: 6701), Hitachi,
Ltd. (Hitachi; TSE: 6501 / NYSE: HIT), and Mitsubishi Electric
Corporation (Mitsubishi Electric; TSE: 6503) today announced c
QUMAS and neeb & partner Announce Partnership JERSEY CITY, NJ -- 11/09/09 --
QUMAS, the leading provider of Compliance
Solutions to highly regulated industries, and neeb & partner GmbH, a
consulting company specializing in the integration of leading content
management solutions to provide ..
QUMAS and neeb & partner Announce Partnership JERSEY CITY, NJ -- 11/09/09 --
QUMAS, the leading provider of Compliance
Solutions to highly regulated industries, and neeb & partner GmbH, a
consulting company specializing in the integration of leading content
management solutions to provide ..
Sappi Limited Results for the Fourth Quarter and Year End September 2009
JOHANNESBURG, Nov. 9 --
Net cash generated US$225 millionRefinancing completed; improved liquidity and extended maturitiesSaiccor Mill ramp up near full capacity at quarter endStronger Rand impacted SA business unfavourably
Epistem Presents GenetRx(TM) Clinical Data on the Use of Scalp Hair to Assess Androgen Receptor Directed Therapies and to Identify Novel Pharmacodynamic Markers for an Antisense Molecule MANCHESTER, UNITED KINGDOM -- 11/09/09 --
Epistem plc (LSE: EHP), the leading biotechnology company, will present results from two recently completed clinical studies. The first study, with a leading pharmaceutical company, demonstrates androgen re..
|
|
|
|
|
|
|
|
|